Home
Our Focus
Overview
Literature & Publications
Pipeline
Overview
Acute Ischemic Stroke
Cardio-Renal Disease
Clinical Trials
Overview
Acute Ischemic Stroke
ReMEDy2
Overview
About ReMEDy2
Stroke Disease
For Physicians
Trial Locations
About DiaMedica
Overview
Leadership
Careers
Contact
Investors Relations
Overview
Press Releases
Events & Presentations
Stock Data
Analyst Coverage
Financial Reports & SEC Filings
Governance
Resources
SEC Filings
Investors Relations
Investors Relations
Overview
Press Releases
Events & Presentations
Stock Data
Nasdaq Quote
Charts
Historical Data
Analyst Coverage
Financial Reports & SEC Filings
SEC Filings
Annual Reports
Tax Information (PFIC)
Governance
Board of Directors
Board Committees
Governance Documents
Resources
Investor Contact
FAQ
Share Consolidation Instructions
Email Alerts
Financial Reports & SEC Filings
SEC Filings
Annual Reports
Tax Information (PFIC)
Filing Type:
View All
10-K
10-K/A
10-Q
20FR12B
20FR12B/A
3
4
424B3
424B4
424B5
8-A12B
8-A12B/A
8-K
8-K/A
ARS
CERT
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
REGDEX
RW
S-1
S-1/A
S-3
S-8
SC 13G
SC 13G/A
UPLOAD
Year:
View All
2023
2022
2021
2020
2019
2018
2014
2007
Date
Form
Description
PDF
XBRL
Pages
01/03/23
4
Statement of changes in beneficial ownership of securities
1
12/12/22
4
Statement of changes in beneficial ownership of securities
1
12/08/22
4
Statement of changes in beneficial ownership of securities
1
12/06/22
SC 13G/A
Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions
8
12/06/22
4
Statement of changes in beneficial ownership of securities
2
12/05/22
4
Statement of changes in beneficial ownership of securities
1
12/05/22
4
Statement of changes in beneficial ownership of securities
1
12/01/22
4
Statement of changes in beneficial ownership of securities
1
11/16/22
4
Statement of changes in beneficial ownership of securities
1
11/09/22
10-Q
Quarterly report pursuant to Section 13 or 15(d)
Documents
EX-31.1
EX-31.2
EX-32.1
EX-32.2
31
Previous
1…
2
3
4
5
6
7
8
9
10
11
…29
Next
Email Alerts
Contacts
RSS News Feed